Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Current Leases (2020 - 2025)

Altimmune (ALT) has disclosed Current Leases for 6 consecutive years, with $256000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases fell 8.24% to $256000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $256000.0 through Dec 2025, down 8.24% year-over-year, with the annual reading at $256000.0 for FY2025, 8.24% down from the prior year.
  • Current Leases for Q4 2025 was $256000.0 at Altimmune, up from $247000.0 in the prior quarter.
  • The five-year high for Current Leases was $508000.0 in Q1 2024, with the low at $239000.0 in Q2 2025.
  • Average Current Leases over 5 years is $382764.7, with a median of $421000.0 recorded in 2022.
  • The sharpest move saw Current Leases rose 15.22% in 2021, then plummeted 51.77% in 2025.
  • Over 5 years, Current Leases stood at $411000.0 in 2021, then grew by 9.98% to $452000.0 in 2022, then grew by 9.73% to $496000.0 in 2023, then tumbled by 43.75% to $279000.0 in 2024, then decreased by 8.24% to $256000.0 in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $256000.0, $247000.0, and $239000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.